15-Year safety check for caribou cell therapy patients
NCT ID NCT05332054
First seen Apr 04, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This study watches over people who have already received Caribou cell therapy in earlier studies. The goal is to track any long-term side effects and safety issues for up to 15 years after treatment. About 150 participants with certain blood cancers will be followed without receiving any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AdventHealth Medical Group Blood & Marrow Transplant at Orlando
Orlando, Florida, 32804, United States
-
Atlantic Health System Cancer Care
Morristown, New Jersey, 07960, United States
-
Augusta University/Georgia Cancer Center
Augusta, Georgia, 30912, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Baylor Research Institute
Dallas, Texas, 75246, United States
-
Blood & Marrow Transplant Group of Georgia
Atlanta, Georgia, 30342, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Honor Health Research Institute
Scottsdale, Arizona, 85258, United States
-
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, 84112, United States
-
Icahn School of Medicine at Mt. Sinai
New York, New York, 10029, United States
-
Levine Cancer Center
Charlotte, North Carolina, 28204, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Oncology Hematology Care
Cincinnati, Ohio, 45242, United States
-
Regional Cancer Care Associates - Hackensack
Hackensack, New Jersey, 07601, United States
-
Sarah Cannon Research Institute - TriStar Health
Nashville, Tennessee, 37203, United States
-
University of Alabama
Birmingham, Alabama, 35233, United States
-
University of California Irvine
Irvine, California, 92868, United States
-
University of California San Diego
La Jolla, California, 92093, United States
-
University of Colorado
Denver, Colorado, 80045, United States
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
-
University of Kentucky
Lexington, Kentucky, 40536, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas Southwestern
Dallas, Texas, 75235, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23284, United States
-
Weill Cornell Medicine
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.